Get bespoke answers to high-stakes questions

Combine our team expertise and AI when your team needs to evaluate a company, map a market, compare competitors or understand the science behind an opportunity.

Already used by Top 10 Big Pharmas

START FROM THE QUESTION

What are you trying to decide?

Every report is commissioned around one question. Pick the closest and see the sample it produces.

Should we back this company?

Who is working in this pathway?

Who are we really competing with?

Does the science hold up?

Explore sample DLT reports

Each sample shows how DLT can turn specialist longevity data into decision-ready intelligence.

01 / SCIENTIFIC ASSESSMENT

Scientific Assessment Report

SAMPLE FOCUS

BioAge Labs

BEST FOR

Investors, pharma BD, scientific strategy teams

A scientific deep dive assessing BioAge’s pipeline, mechanism strategy and competitive position. The sample frames BioAge as an inflammaging and metabolic-resilience company, with particular focus on BGE-102, an oral brain-penetrant NLRP3 inhibitor, and its APJ/apelin obesity programs.

WHAT’S INSIDE

02 / INVESTOR MARKET

Investor Market Report

SAMPLE FOCUS

Mitochondrial dysfunction

BEST FOR

Investors, BD teams, market strategy teams

A market landscape report identifying companies showing “solid progress” in mitochondrial dysfunction. The sample highlights 196 companies with assets tied to mitochondrial mechanisms, then shortlists late-stage leaders including Stealth BioTherapeutics, Mitotech, Khondrion, GenSight, Clene, Cerecin and T3D Therapeutics.

WHAT’S INSIDE

03 / DUE DILIGENCE

Due Diligence Report

SAMPLE FOCUS

Series B biotech diligence

BEST FOR

VCs, growth investors, strategic investors

A diligence memo built around a 3–5 year investment horizon. The sample assesses a Series B opportunity, reviewing clinical milestones, use of proceeds, scientific risk, commercial dynamics, IP questions and go/no-go criteria.

WHAT’S INSIDE

04 / COMPETITOR ANALYSIS

Competitor Analysis Report

SAMPLE FOCUS

Arrowhead Pharmaceuticals

BEST FOR

Strategy teams, BD, competitive intelligence, biotech leadership

A competitor intelligence report mapping Arrowhead’s peer set across capital raised and therapeutic overlap. The sample identifies direct peer tiers, competitor density across therapeutic areas and top competitors by category, including cardiovascular, geroscience, immunology, metabolic, neurology and pulmonology.

WHAT’S INSIDE

FOUR STEPS

How it works?

01

Define the brief

Tell us the company, market, pathway, asset or strategic question you need answered.

02

Build intelligence set

DLT pulls from specialist longevity company, asset, market, funding, IP, trial and signal data.

03

Analyse the opportunity

We assess the science, market, competitors, risks and strategic implications.

04

Deliver the report

You receive a clear, decision-ready report built for internal use, investment review, BD or strategy planning.

CUSTOM RESEARCH

Bring one live question to a 30-minute call

We run the call against the live dataset. Tell us the mechanism, indication or competitor set you are working on and we will show you what DLT holds on it.

TRACEABLE

Every company, asset, patent and financing referenced in a report comes from a DLT record, so a claim can be followed back to the profile it came from.

SPECIALIST

Coverage is curated by the Longevity.Technology research team rather than scraped, across companies worldwide whose science maps to aging biology.

LINKED

Companies, assets, targets, patents, investors and people sit in one model, which is what makes peer sets and competitor density calculable rather than assembled by hand.

CURRENT

Signal feeds run daily and records are reviewed continuously, so a report reflects the dataset on the day it is written.

Need a deeper answer?

Commission a DLT custom report built around your strategic question.